OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and Emerging Targeted Therapies for Vascular Malformations
An Van Damme, Emmanuel Seront, Valérie Dekeuleneer, et al.
American Journal of Clinical Dermatology (2020) Vol. 21, Iss. 5, pp. 657-668
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Genetic Basis and Therapies for Vascular Anomalies
Angela Queisser, Emmanuel Seront, Laurence M. Boon, et al.
Circulation Research (2021) Vol. 129, Iss. 1, pp. 155-173
Open Access | Times Cited: 159

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations
Guillaume Canaud, Adrienne M. Hammill, Denise M. Adams, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 108

Updates on Sturge-Weber Syndrome
SangEun Yeom, Anne M. Comi
Stroke (2022) Vol. 53, Iss. 12, pp. 3769-3779
Open Access | Times Cited: 48

Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations
Emmanuel Seront, An Van Damme, Catherine Legrand, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 25

Infantile hemangioma: the common and enigmatic vascular tumor
Annegret Holm, John B. Mulliken, Joyce Bischoff
Journal of Clinical Investigation (2024) Vol. 134, Iss. 8
Open Access | Times Cited: 12

Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations
Pascal Brouillard, Matthieu J. Schlögel, Nassim Homayun Sepehr, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 42

The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
Piotr Kobialka, Helena Sabata, Odena Vilalta, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 7
Open Access | Times Cited: 37

Case report study of thalidomide therapy in 18 patients with severe arteriovenous malformations
Laurence M. Boon, Valérie Dekeuleneer, Julien Coulie, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 6, pp. 562-567
Closed Access | Times Cited: 31

Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations – A nationwide trial
Veroniek E. M. Harbers, Lilly Geertruida Johanna Maria Zwerink, Gerard A. Rongen, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 5, pp. 781-796
Open Access | Times Cited: 18

Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema
Alicia B. Byrne, Pascal Brouillard, Drew L. Sutton, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 634
Closed Access | Times Cited: 25

Targeting the microenvironment in the treatment of arteriovenous malformations
Caroline T. Seebauer, Benedikt Wiens, Constantin A. Hintschich, et al.
Angiogenesis (2023) Vol. 27, Iss. 1, pp. 91-103
Open Access | Times Cited: 14

Shear stress and pathophysiological PI3K involvement in vascular malformations
Salim Abdelilah‐Seyfried, Roxana Ola
Journal of Clinical Investigation (2024) Vol. 134, Iss. 10
Open Access | Times Cited: 6

Targeted Treatments for Vascular Malformations: Current State of the Art.
Emmanuel Seront, Cédric Hermans, Laurence M. Boon, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 2961-2975
Closed Access | Times Cited: 6

Comprehensive phenotypic and genomic characterization of venous malformations
Katsutoshi Hirose, Yumiko Hori, Michio Ozeki, et al.
Human Pathology (2024) Vol. 145, pp. 48-55
Open Access | Times Cited: 5

Assessment of gene–disease associations and recommendations for genetic testing for somatic variants in vascular anomalies by VASCERN-VASCA
Nicole Revençu, Astrid Eijkelenboom, Claire Bracquemart, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5

Trametinib as a promising therapeutic option in alleviating vascular defects in an endothelial KRAS-induced mouse model
Ha‐Long Nguyen, Laurence M. Boon, Miikka Vikkula
Human Molecular Genetics (2022) Vol. 32, Iss. 2, pp. 276-289
Closed Access | Times Cited: 22

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
Martin Štěrba, Petra Pokorná, Renata Faberova, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Current concepts of vascular anomalies
Tae Hyung Kim, Jong Woo Choi, Woo Shik Jeong
Archives of Craniofacial Surgery (2023) Vol. 24, Iss. 4, pp. 145-158
Open Access | Times Cited: 10

Genotyping as Part of Routine Clinical Care—The Outcomes for a Large Paediatric Vascular Anomaly Cohort
S. S. O'Sullivan, Maria Shilova, Angharad Webb, et al.
American Journal of Medical Genetics Part A (2025)
Closed Access

Human iPSCs offer an alternative for modeling vascular malformation
Stefanie DeFronzo, Guohao Dai
Cell stem cell (2025) Vol. 32, Iss. 2, pp. 177-178
Closed Access

Trastornos que afectan a la vascularización cutánea: malformaciones vasculares
J.-M. L’Orphelin, A. Dompmartin
EMC - Dermatología (2025) Vol. 59, Iss. 1, pp. 1-13
Closed Access

RAS Pathway Mutations and Therapeutics in Vascular Anomalies
Sara Alharbi, Svatava Merkle, Adrienne M. Hammill, et al.
Pediatric Blood & Cancer (2025)
Open Access

Kinderorthopädie bei angeborenen Gefäßanomalien
Michael Kertai, Luise Metzger, Vavra Zbynek, et al.
Monatsschrift Kinderheilkunde (2025)
Closed Access

Page 1 - Next Page

Scroll to top